4-(MORPHOLINOMETHYL)-3-(TRIFLUOROMETHYL)ANILINE, 95.0%, 1g

(2e)-3-(Quinolin-6-yl)prop-2-enoic acid, 98%, 10g

7-Chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 95.0%, 100mg

2-Chloro-5-hydroxynicotinic acid, 95.0%, 250mg

tert-Butyl benzyl(5-chloro-3-isopropylpyrazolo[1,5-a]pyrimidin-7-yl)carbamate, 97%, 10g

4-Bromo-5-fluoropyridin-2-amine, 95%, 100mg

6-ethoxy-2,3-dihydroinden-1-one, 97%, 500mg

tert-Butyl 6-oxo-2,5-diazaspiro[3.4]octane-2-carboxylate, 98%, 2g

Benzyl 3-oxopentanoate, 95%, 1g

2-Amino-5-chloro-6-fluorobenzonitrile, 95.0%, 5g

2-Amino-3-fluorobenzaldehyde, 95.0%, 5g

GC capillary column ROTI®Cap-1701, 25 m, 0.32 mm, 0.50 µm, 1 Piece(s)

(-)-10-Camphorsulfonic Acid>98.0%(T)25g